Mytide Therapeutics: Funding, Investors & Team (Oct 2026)
Mytide is committed to providing peptides to serve a diverse array of applications. During their beta phase, they intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. We provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display with guaranteed purities of >90%, 3 mg quantities, and 5-day turnaround of peptides up to length 40 AA.
Mytide Therapeutics has raised $7.0M across 1 funding round on record, the most recent a Series A of $7.0M announced in Mar 2022.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mytide Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Mytide Therapeutics Funding Rounds
Mytide Therapeutics Founders and Leadership Team
Contact details for the Mytide Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Mytide Therapeutics Funding Compared to Other Biotechnology Startups
Mytide Therapeutics' latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mytide Therapeutics in Biotechnology and Boston
Companies Similar to Mytide Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Mytide Therapeutics Funding FAQs
What does Mytide Therapeutics do?
Mytide is committed to providing peptides to serve a diverse array of applications. During their beta phase, they intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. We provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display with guaranteed purities of >90%, 3 mg quantities, and 5-day turnaround of peptides up to length 40 AA.
How much funding has Mytide Therapeutics raised?
Mytide Therapeutics has raised $7.0M across 1 round on record. The most recent is a Series A of $7.0M announced in Mar 2022.
When did Mytide Therapeutics last raise funding?
Mytide Therapeutics' most recent funding round on record is a Series A of $7.0M, announced in Mar 2022.
Who founded Mytide Therapeutics?
FundedIQ lists Dale Thomas (Founder) at Mytide Therapeutics.
Where is Mytide Therapeutics headquartered?
Mytide Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Mytide Therapeutics have?
Mytide Therapeutics is in the 11-50 employee band.
How does Mytide Therapeutics' funding compare to other Biotechnology startups?
Mytide Therapeutics' latest round of $7.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Mytide Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mytide Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.